Nautilus, Inc. Reports Fiscal First Quarter 2023 Results
Nautilus, Inc. (NYSE: NLS) achieved Q1 Fiscal 2023 revenue of $54.8M, a decline of 70.3% year-over-year, yet beat adjusted EBITDA expectations. Direct net sales reached $26.5M, marking a 27% increase from pre-pandemic levels, while JRNY® membership surged by 133% to 360,000 compared to Q1 Fiscal 2022. Gross profit fell to $7.0M with a margin of 12.7%. Operating loss reached $51.2M, driven by a $27.0M impairment charge. Nautilus reiterated its full-year guidance, projecting continued JRNY® growth and a positive EBITDA outlook for H2 2023.
- Direct net sales increased by 27% compared to pre-pandemic Q1 Fiscal 2020.
- JRNY® membership grew by 133% year-over-year, reaching 360,000 members.
- The company reiterated its full-year financial guidance and JRNY® member growth expectations.
- Net sales decreased 70.3% compared to the previous year.
- Gross profit dropped to $7.0M, with a significant decline in gross margin to 12.7%.
- Operating loss escalated to $51.2M due to a substantial impairment charge.
Company Achieves Upper End Q1 Fiscal 2023 Revenue Guidance and Beats Adjusted EBITDA Guidance
Direct
JRNY® Total Members Reaches 360k with
Company Reiterates Full Year Guidance
Management Comments
“We are pleased to deliver solid first quarter results that reflect the execution of our multi-year transformation plan. Our omnichannel approach was critical to our success in the quarter, with Direct channel sales up
Total Company Results
For fiscal 2023, Nautilus expects to return to a more typical pre-pandemic seasonality, with the 2nd Half of the year contributing more of the full year's revenue. Additionally, to gauge sales growth and progress against more "normalized" or pre-pandemic results, the Company will rely more heavily on measuring performance of fiscal 2023 sales growth versus the pre-pandemic twelve-month period that ended
Fiscal 2023 First Quarter Ended
-
Net sales were
, compared to$54.8 million , a decline of$184.6 million 70.3% versus last year. Net sales are up11% , or3% CAGR, when compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold inOctober 2020 . The sales decline versus last year is driven primarily by the return to pre-pandemic seasonal demand. -
Gross profit was
, compared to$7.0 million last year. Gross profit margins were$55.5 million 12.7% compared to30.1% last year. The 17.4 ppt decrease in gross margins was primarily due to increased discounting (-8 ppts), unfavorable logistics overhead absorption (-8 ppts), and increased investments in JRNY® (-4 ppts), offset by improvement in other costs (3 ppts). -
Operating expenses were
, an increase of$58.1 million , or$20.5 million 54.5% , compared to last year, primarily due to a goodwill and intangible impairment charge of and a$27.0 million increase in JRNY® investments, partially offset by$3.6 million lower media spending and$5.7 million lower other variable selling and marketing expenses due to decreased sales. Total advertising expenses were$2.7 million versus$5.1 million last year.$10.8 million -
Operating loss was
or negative$51.2 million 93.4% operating margin, compared to operating income of last year, primarily driven by a goodwill and intangible impairment charge of$17.9 million and lower gross profit associated with lower sales demand during the period.$27.0 million -
Loss from continuing operations was
, or$60.2 million per diluted share, compared to income of$(1.92) , or$14.0 million per diluted share, last year.$0.43 -
Net loss was
, or$60.2 million per diluted share, compared to net income of$(1.92) , or$13.9 million per diluted share, last year.$0.43 -
The income tax expense was
this year compared to$8.1 million last year. The income tax expense this year was primarily a result of a$3.4 million U.S. deferred tax asset valuation allowance in the amount of recorded this quarter.$14.2 million -
The following statements exclude the impact of non-cash impairment charges1 related to the carrying value of our goodwill and intangible assets for the three-months ended
June 30, 2022 .-
Adjusted operating expenses were
, or$31.2 million 56.9% of sales, compared to , or$37.6 million 20.4% of sales, last year. The decrease was driven by lower advertising and partially offset by JRNY® investments. -
Adjusted operating loss was
compared to last year’s income of$24.2 million , driven by lower gross profit.$17.9 million -
Adjusted EBITDA loss from continuing operations was
compared to income of$19.9 million last year.$21.1 million
-
Adjusted operating expenses were
1 See “Reconciliation of Non-GAAP Financial Measures” for more information |
JRNY® Update
- Nautilus is continuing to enhance the JRNY® platform through many unique features including the expansion of differentiated, visual connected fitness experiences for JRNY® Members.
-
As of
June 30, 2022 , Members of JRNY®, Nautilus’ personalized connected fitness platform, exceeded 360k representing approximately133% growth versus the same quarter last year. Of these members, 127k were Subscribers, representing approximately290% growth over the same period. We define JRNY® Members as all individuals who have a JRNY® account and/or subscription, which includes Subscribers, their respective associated users and users who consume free content. We define Subscribers as a person or household who paid for a Subscription, are in a trial, or have requested a "pause"' to their subscriptions for up to three months. -
Additionally, the Company has made great strides over the last two years expanding the number of products featuring JRNY® connectivity. In FY 2022, approximately
80% of total units sold were JRNY® compatible, compared to only22% in the pre-pandemic FY 2020. The trend of approximately80% of total units sold being JRNY® compatible continued in Q1 FY 2023. - Nautilus' integration of VAY's motion-tracking capabilities into JRNY® will further advance and accelerate personalized strength workout options, including the addition of rep counting and form coaching for SelectTech® users, which we believe will drive JRNY® membership growth during FY 2023.
Segment Results
Fiscal 2023 First Quarter Ended
Direct Segment
-
Direct segment sales were
, compared to$26.5 million , a decline of$63.4 million 58.2% versus last year, and up27% , or8% CAGR, compared to the same period in fiscal 2020. Net sales decrease was primarily driven by the return to pre-pandemic seasonal demand and higher sales discounting. -
Cardio sales declined
45.5% versus last year and were up6.5% , or2% CAGR, compared to the same period in fiscal 2020. Lower sales were primarily driven by lower bike demand. Strength product sales declined70.8% versus last year and increased96.7% , or25% CAGR, compared to the same period in fiscal 2020. Lower sales this quarter were primarily driven by lower demand for SelectTech® weights. -
The Direct segment ended the quarter with
of backlog as of$0.4 million June 30, 2022 . These amounts represent unfulfilled consumer orders net of current promotional programs and sales discounts. -
Gross profit margin was
17.2% versus38.7% last year. The 21.5 ppt decrease in gross margin was primarily driven by: increased discounting (-8 ppts), unfavorable logistics overhead absorption (-7 ppts) and increased investments in JRNY® (-7 ppts). Gross profit was , down$4.6 million 81.4% versus last year. -
Segment contribution loss was
, or$9.9 million 37.4% of sales, compared to segment contribution income of , or$6.8 million 10.7% of sales last year. The decline was primarily driven by lower gross profit, as explained above, offset by decreased media spend. Advertising expenses were compared to$5.2 million last year.$8.0 million
Retail Segment
-
Retail segment sales were
, down by$27.4 million 77.2% versus last year. Excluding sales related to Octane, net sales were down2% , or -1% CAGR, compared to the same period in fiscal 2020. Retail segment sales outsidethe United States andCanada were down83% versus last year. The decrease in sales compared to last year is primarily driven by lower cardio sales and higher sales discounting as Retailers work through higher-than-normal inventory levels. -
Cardio sales declined by
86.8% versus last year. Excluding sales of the Octane brand, cardio sales were down28.7% , or11% CAGR, compared to the same period in fiscal 2020. Lower sales this quarter were primarily driven by lower bike sales. Strength product sales declined by48.9% versus last year. Strength sales were up36.8% or11% CAGR, compared to the same period in fiscal 2020, led by the popular SelectTech® weights. -
As of
June 30, 2022 , the Retail segment's backlog totaled . These amounts represent customer orders for future shipments and are net of contractual rebates and consideration payable to applicable Retail customers.$48.0 million -
Gross profit margins were
5.5% compared to25.1% last year. The 19.6 ppt decrease in gross margin was primarily driven by: increased discounting (-11 ppts) and unfavorable logistics overhead absorption (-9 ppts). Gross profit was , a decrease of$1.5 million 95% versus last year. -
Segment contribution loss was
, or$5.4 million 19.7% of sales, compared to segment contribution income of , or$22.1 million 18.3% of sales, last year. The decline was primarily driven by lower gross profit as explained above.
Balance Sheet and Other Key Highlights as of
-
Cash and Liquidity:
-
Cash, cash equivalents, and restricted cash were
, compared to cash, cash equivalents, and restricted cash of$8.7 million as of$14.2 million March 31, 2022 . The decrease was primarily due to the net loss, offset by increased debt and changes in working capital. -
Debt and other borrowings were
compared to$37.0 million as of$29.4 million March 31, 2022 . -
was available for borrowing under the Wells Fargo Asset Based Lending Revolving Facility (“Facility”) compared to$35.1 million as of$65.8 million March 31, 2022 .
-
Cash, cash equivalents, and restricted cash were
-
Inventory was
, down compared to$103.9 million as of$111.2 million March 31, 2022 . The decrease in inventory versus year-end was driven by sell-through as we right-size inventory levels ahead of the fitness season. About8% of inventory as ofJune 30, 2022 was in transit. -
Trade receivables were
, compared to$27.5 million as of$61.5 million March 31, 2022 . The decrease in trade receivables was due to lower sales and the timing of customer payments. -
Trade payables were
, compared to$26.8 million as of$53.2 million March 31, 2022 . The decrease in trade payables was primarily due to the timing of payments for inventory. -
Capital expenditures totaled
for the three-months ended$3.4 million June 30, 2022 .
Forward Looking Guidance
The following forward-looking statements reflect the Company's full fiscal year 2023 expectations as of
- The Company is reiterating Second Half and Full Year 2023 Guidance.
Second Half and Full Year 2023
-
The Company expects full year revenue of between
and$380 million .$460 million -
Given the impact of elevated inventory levels at the Company’s retail partners, the Company expects the 2nd half of the year to represent between
65% and70% of full year sales, slightly higher than pre-pandemic 2nd half seasonality of approximately60% . -
Gross margins for the second half of the year are expected to be in the range of
27% to30% . Improvements versus last year are driven by lower in-bound freight and demurrage fees, and the reduction in logistics facilities footprint. The Company is closing one of its distribution centers when the associated lease expires in the Fall of 2022 and will not be renewing the leases of some storage locations. - Given higher anticipated sales levels in the 2nd half of FY 2023, improved gross margins, and plans to flex sales and marketing expenses in-line with sales, the Company expects to deliver positive Adjusted EBITDA(1) for the 2nd half of FY 2023.
-
As a result, the Company expects full year Adjusted EBITDA(1) loss of between
and$25 million .$35 million -
The Company expects JRNY® Members to exceed 500,000 at
March 31, 2023 .
(1) We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent unpredictability of forecasting certain types of expenses such as stock-based compensation and income tax expenses, which affect net income but not Adjusted EBITDA. We are unable to reasonably estimate the impact of such expenses, if any, on net income. The inability to project certain components of the calculation would significantly affect the accuracy of a reconciliation. Accordingly, we do not provide a reconciliation of projected net income to projected Adjusted EBITDA. |
Conference Call
Nautilus will discuss our fiscal 2023 first quarter ended
A telephonic playback will be available from
About
Headquartered in
Forward-Looking Statements
This press release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including: projected, targeted or forecasted financial, operating results and capital expenditures, including but not limited to net sales growth rates, gross margins, operating expenses, operating margins, anticipated demand for the Company's new and existing products, statements regarding the Company's prospects, resources or capabilities; planned investments, strategic initiatives and the anticipated or targeted results of such initiatives; the effects of the COVID-19 pandemic on the Company’s business; and planned operational initiatives and the anticipated cost-saving results of such initiatives. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause Nautilus, Inc.’s actual expectations to differ materially from these forward-looking statements also include: weaker than expected demand for new or existing products; our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs; risks associated with current and potential delays, work stoppages, or supply chain disruptions, including shipping delays due to the severe shortage of shipping containers; an inability to pass along or otherwise mitigate the impact of raw material price increases and other cost pressures, including unfavorable currency exchange rates and increased shipping costs; experiencing delays and/or greater than anticipated costs in connection with launch of new products, entry into new markets, or strategic initiatives; our ability to hire and retain key management personnel; changes in consumer fitness trends; changes in the media consumption habits of our target consumers or the effectiveness of our media advertising; a decline in consumer spending due to unfavorable economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crises; softness in the retail marketplace; availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms and the impact of any future impairment. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the
RESULTS OF OPERATIONS INFORMATION
The following summary contains information from our consolidated statements of operations for the three-month period ended
|
Three-Months Ended
|
||||||
|
|
2022 |
|
|
|
2021 |
|
Net sales |
$ |
54,817 |
|
|
$ |
184,593 |
|
Cost of sales |
|
47,860 |
|
|
|
129,088 |
|
Gross profit |
|
6,957 |
|
|
|
55,505 |
|
Operating expenses: |
|
|
|
||||
Selling and marketing |
|
12,891 |
|
|
|
21,300 |
|
General and administrative |
|
12,463 |
|
|
|
11,523 |
|
Research and development |
|
5,823 |
|
|
|
4,815 |
|
|
|
26,965 |
|
|
|
— |
|
Total operating expenses |
|
58,142 |
|
|
|
37,638 |
|
|
|
|
|
||||
Operating (loss) income |
|
(51,185 |
) |
|
|
17,867 |
|
Other expense, net |
|
(889 |
) |
|
|
(413 |
) |
(Loss) income from continuing operations before income taxes |
|
(52,074 |
) |
|
|
17,454 |
|
Income tax expense |
|
8,096 |
|
|
|
3,438 |
|
(Loss) income from continuing operations |
|
(60,170 |
) |
|
|
14,016 |
|
Loss from discontinued operations, net of income taxes |
|
(7 |
) |
|
|
(132 |
) |
Net (loss) income |
$ |
(60,177 |
) |
|
$ |
13,884 |
|
|
|
|
|
||||
Basic (loss) income per share from continuing operations |
$ |
(1.92 |
) |
|
$ |
0.46 |
|
Basic loss per share from discontinued operations |
|
— |
|
|
|
(0.01 |
) |
Basic net (loss) income per share |
$ |
(1.92 |
) |
|
$ |
0.45 |
|
|
|
|
|
||||
Diluted (loss) income per share from continuing operations |
$ |
(1.92 |
) |
|
$ |
0.43 |
|
Diluted loss per share from discontinued operations |
|
— |
|
|
|
— |
|
Diluted net (loss) income per share |
$ |
(1.92 |
) |
|
$ |
0.43 |
|
|
|
|
|
||||
Shares used in per share calculations: |
|
|
|
||||
Basic |
|
31,405 |
|
|
|
30,697 |
|
Diluted |
|
31,405 |
|
|
|
32,508 |
|
|
|
|
|
||||
Select Metrics: |
|
|
|
||||
Gross margin |
|
12.7 |
% |
|
|
30.1 |
% |
Selling and marketing % of net sales |
|
23.5 |
% |
|
|
11.5 |
% |
General and administrative % of net sales |
|
22.7 |
% |
|
|
6.2 |
% |
Research and development % of net sales |
|
10.6 |
% |
|
|
2.6 |
% |
Operating (loss) income % of net sales |
|
(93.4 |
) % |
|
|
9.7 |
% |
SEGMENT INFORMATION
The following table presents certain comparative information by segment and major product lines within each business segment for the three-months ended
|
Three-Months Ended
|
|
Change |
|||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
$ |
|
% |
|||
Net sales: |
|
|
|
|
|
|
|
|||||||
Direct net sales: |
|
|
|
|
|
|
|
|||||||
Cardio products(1) |
$ |
17,133 |
|
|
$ |
31,430 |
|
|
$ |
(14,297 |
) |
|
(45.5 |
) % |
Strength products(2) |
|
9,343 |
|
|
|
31,966 |
|
|
|
(22,623 |
) |
|
(70.8 |
) % |
Direct |
|
26,476 |
|
|
|
63,396 |
|
|
|
(36,920 |
) |
|
(58.2 |
) % |
|
|
|
|
|
|
|
|
|||||||
Retail net sales: |
|
|
|
|
|
|
|
|||||||
Cardio products(1) |
|
11,843 |
|
|
|
89,924 |
|
|
|
(78,081 |
) |
|
(86.8 |
) % |
Strength products(2) |
|
15,601 |
|
|
|
30,560 |
|
|
|
(14,959 |
) |
|
(48.9 |
) % |
Retail |
|
27,444 |
|
|
|
120,484 |
|
|
|
(93,040 |
) |
|
(77.2 |
) % |
|
|
|
|
|
|
|
|
|||||||
Royalty |
|
897 |
|
|
|
713 |
|
|
|
184 |
|
|
25.8 |
% |
Consolidated net sales |
$ |
54,817 |
|
|
$ |
184,593 |
|
|
$ |
(129,776 |
) |
|
(70.3 |
) % |
|
|
|
|
|
|
|
|
|||||||
Gross profit: |
|
|
|
|
|
|
|
|||||||
Direct |
$ |
4,562 |
|
|
$ |
24,514 |
|
|
$ |
(19,952 |
) |
|
(81.4 |
) % |
Retail |
|
1,498 |
|
|
|
30,278 |
|
|
|
(28,780 |
) |
|
(95.1 |
) % |
Royalty |
|
897 |
|
|
|
713 |
|
|
|
184 |
|
|
25.8 |
% |
Consolidated gross profit |
$ |
6,957 |
|
|
$ |
55,505 |
|
|
$ |
(48,548 |
) |
|
(87.5 |
) % |
|
|
|
|
|
|
|
|
|||||||
Gross margin: |
|
|
|
|
|
|
|
|||||||
Direct |
|
17.2 |
% |
|
|
38.7 |
% |
|
|
(2,150 |
) |
basis points |
||
Retail |
|
5.5 |
% |
|
|
25.1 |
% |
|
|
(1,960 |
) |
basis points |
||
|
|
|
|
|
|
|
|
|||||||
Contribution: |
|
|
|
|
|
|
|
|||||||
Direct |
$ |
(9,893 |
) |
|
$ |
6,759 |
|
|
$ |
(16,652 |
) |
|
(246.4 |
) % |
Retail |
|
(5,408 |
) |
|
|
22,090 |
|
|
|
(27,498 |
) |
|
(124.5 |
) % |
Royalty |
|
897 |
|
|
|
713 |
|
|
|
184 |
|
|
25.8 |
% |
Consolidated contribution |
$ |
(14,404 |
) |
|
$ |
29,562 |
|
|
$ |
(43,966 |
) |
|
(148.7 |
) % |
|
|
|
|
|
|
|
|
|||||||
Reconciliation of consolidated contribution to (loss) income from continuing operations: |
||||||||||||||
Consolidated contribution |
$ |
(14,404 |
) |
|
$ |
29,562 |
|
|
$ |
(43,966 |
) |
|
(148.7 |
) % |
Amounts not directly related to segments: |
|
|
|
|
|
|
|
|||||||
Operating expenses |
|
(36,781 |
) |
|
|
(11,695 |
) |
|
|
(25,086 |
) |
|
(214.5 |
) % |
Other expense, net |
|
(889 |
) |
|
|
(413 |
) |
|
|
(476 |
) |
|
(115.3 |
) % |
Income tax benefit (expense) |
|
(8,096 |
) |
|
|
(3,438 |
) |
|
|
(4,658 |
) |
|
(135.5 |
) % |
(Loss) income from continuing operations |
$ |
(60,170 |
) |
|
$ |
14,016 |
|
|
$ |
(74,186 |
) |
|
(529.3 |
) % |
(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, Bowflex® VeloCore®, Schwinn® IC4, |
(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories. |
BALANCE SHEET INFORMATION
The following summary contains information from our consolidated balance sheets as of
|
As of |
||||
|
|
|
|
||
Assets |
|
|
|
||
|
|
|
|
||
Cash and cash equivalents |
$ |
7,311 |
|
$ |
12,872 |
Restricted cash |
|
1,339 |
|
|
1,339 |
Available-for-sale securities |
|
— |
|
|
— |
Trade receivables, net of allowances |
|
27,450 |
|
|
61,454 |
Inventories |
|
103,932 |
|
|
111,190 |
Prepaids and other current assets |
|
11,979 |
|
|
14,546 |
Other current assets - restricted, current |
|
3,887 |
|
|
3,887 |
Income taxes receivable |
|
1,721 |
|
|
1,998 |
Total current assets |
|
157,619 |
|
|
207,286 |
Property, plant and equipment, net |
|
33,185 |
|
|
32,129 |
Operating lease right-of-use assets |
|
22,353 |
|
|
23,620 |
|
|
— |
|
|
24,510 |
Other intangible assets, net |
|
6,833 |
|
|
9,304 |
Deferred income tax assets, non-current |
|
809 |
|
|
8,760 |
Income taxes receivable, non-current |
|
5,673 |
|
|
5,673 |
Other assets |
|
2,666 |
|
|
2,763 |
Total assets |
$ |
229,138 |
|
$ |
314,045 |
|
|
|
|
||
Liabilities and Shareholders' Equity |
|
|
|
||
|
|
|
|
||
Trade payables |
$ |
26,764 |
|
$ |
53,165 |
Accrued liabilities |
|
24,420 |
|
|
29,386 |
Operating lease liabilities, current portion |
|
4,316 |
|
|
4,494 |
Finance lease liabilities, current portion |
|
120 |
|
|
119 |
Warranty obligations, current portion |
|
3,955 |
|
|
4,968 |
Income taxes payable, current portion |
|
720 |
|
|
839 |
Debt payable, current portion, net of unamortized debt issuance costs |
|
2,243 |
|
|
2,243 |
Total current liabilities |
|
62,538 |
|
|
95,214 |
Operating lease liabilities, non-current |
|
19,778 |
|
|
20,926 |
Finance lease liabilities, non-current |
|
367 |
|
|
395 |
Warranty obligations, non-current |
|
1,041 |
|
|
1,248 |
Income taxes payable, non-current |
|
4,054 |
|
|
4,029 |
Deferred income tax liabilities, non-current |
|
500 |
|
|
— |
Other non-current liabilities |
|
1,270 |
|
|
1,071 |
Debt payable, non-current, net of unamortized debt issuance costs |
|
34,743 |
|
|
27,113 |
Shareholders' equity |
|
104,847 |
|
|
164,049 |
Total liabilities and shareholders' equity |
$ |
229,138 |
|
$ |
314,045 |
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
Non-GAAP Presentation
In addition to disclosing its financial results determined in accordance with GAAP, Nautilus has presented in this release certain non-GAAP financial measures, which exclude the impact of certain items (as further described below) and provide supplemental information regarding operating performance. Nautilus presents non-GAAP financial measures as a complement to results provided in accordance with GAAP, and the non-GAAP financial measures should not be regarded as a substitute for GAAP. By disclosing these non-GAAP financial measures, management intends to provide investors with a supplemental comparison of operating results and trends for the periods presented. Management believes these measures are also useful to investors as such measures allow investors to evaluate performance using the same metrics that management uses to evaluate past performance and prospects for future performance. Nautilus strongly encourages you to review all its financial statements and publicly filed reports in their entirety and to not rely on any single financial measure.
Adjusted Results
In addition to disclosing the comparable GAAP results, Nautilus has presented its operating expenses and operating (loss) income on an adjusted basis. Adjusted operating expenses and Adjusted operating (loss) income excludes the non-cash charges related to the non-cash charge related to goodwill and intangible asset impairment. We believe that the adjustment of these charges and any associated tax benefit, which are inconsistent in amount and frequency, supplements the GAAP information with a measure that can be used to assess the sustainability of our operating performance. Nautilus has also presented EBITDA from continuing operations on an adjusted basis, excluding the aforementioned items for similar reasons.
Adjusted EBITDA from Continuing Operations
Nautilus has also presented EBITDA from continuing operations on an adjusted basis, to exclude the non-cash charge related to goodwill and intangible asset impairment, stock-based compensation expense, and other expenses, net. We believe that the exclusion of stock-based compensation expense provides for a better comparison of our operating results to prior periods and to our peer companies as the calculations of stock-based compensation vary from period to period and company to company due to different valuation methodologies, subjective assumptions, and the variety of award types. We exclude other expenses, net that are the result of factors and can vary significantly from one period to the next, we believe that exclusion of such other expenses are useful to management and investors in evaluating the performance of our ongoing operations on a period-to-period basis. We believe that the adjustment of this charge, which is inconsistent in amount and frequency, supplements the EBITDA information with a measure that can be used to assess the sustainability of our operating performance.
The following table presents a reconciliation of operating expenses, the most directly comparable GAAP measure, to Adjusted operating expenses for the three-month period ended
|
Three-Months Ended
|
|||||
|
2022 |
|
2021 |
|||
Operating expenses |
$ |
58,142 |
|
|
$ |
37,638 |
|
|
(26,965 |
) |
|
|
— |
Adjusted operating expenses |
$ |
31,177 |
|
|
$ |
37,638 |
The following table presents a reconciliation of operating (loss) income, the most directly comparable GAAP measure, to Adjusted operating (loss) income for the three-month period ended
|
Three-Months Ended
|
|||||
|
2022 |
|
2021 |
|||
Operating (loss) income |
$ |
(51,185 |
) |
|
$ |
17,867 |
|
|
26,965 |
|
|
|
— |
Adjusted operating (loss) income |
$ |
(24,220 |
) |
|
$ |
17,867 |
The following table presents a reconciliation of (loss) income from continuing operations, the most directly comparable GAAP measure, to Adjusted EBITDA from continuing operations for the three-month period ended
|
Three-Months Ended
|
|||||
|
2022 |
|
2021 |
|||
(Loss) income from continuing operations |
$ |
(60,170 |
) |
|
$ |
14,016 |
Other expense, net |
|
889 |
|
|
|
413 |
Income tax expense from continuing operations |
|
8,096 |
|
|
|
3,438 |
Depreciation and amortization |
|
2,306 |
|
|
|
2,054 |
Stock-based compensation expense |
|
1,979 |
|
|
|
1,225 |
|
|
26,965 |
|
|
|
— |
Adjusted (loss) earnings before interest, taxes, depreciation, and amortization (Adjusted EBITDA) from continuing operations |
$ |
(19,935 |
) |
|
$ |
21,146 |
(1)
In accordance with ASC 350 — Intangibles —
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005969/en/
Investor Relations:
646-277-1254
John.mills@icrinc.com
Media:
360-859-5815
jfread@nautilus.com
The
503-754-7975
ckerns@hoffman.com
Source:
FAQ
What was Nautilus's revenue for Q1 Fiscal 2023?
How much did Nautilus's JRNY® membership grow?
What were the key financial highlights for Nautilus in Q1 Fiscal 2023?